BRAIN Biotech receives EUR 11.51 million milestone payment from Royalty Pharma

Reuters2026/09/09 11:14

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

BRAIN Biotech received a EUR 11.51 million milestone payment from Royalty Pharma tied to deucrictibant development progress.
Clinical progress lifted the likelihood of further regulatory and commercial milestone payments of up to EUR 96.65 million under the Sept. 20, 2024 agreement.
IFRS 9 liability revaluation may trigger a one-time, non-cash P&L charge of up to EUR 28 million in fiscal 2025/26.
Adjusted group EBITDA guidance stays around break-even for the year.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BRAIN Biotech AG published the original content used to generate this news brief via EQS News (Ref. ID: adhoc_2396744_en) on September 09, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

BRAIN Biotech receives EUR 11.51 million milestone payment from Royalty Pharma

You may also like

Crypto prices